108 related articles for article (PubMed ID: 9463114)
1. [First-time standard setting for therapy of pulmonary tuberculosis after revision of the Medical Treatment Standard--special reference to results of questionnaire survey on reality of early stage short-term PZA therapy and occurrence of the adverse effects].
Kekkaku; 1997 Nov; 72(11):639-42. PubMed ID: 9463114
[No Abstract] [Full Text] [Related]
2. [Comparison of drug-induced hepatitis occurring in elderly and younger patients during anti-tuberculosis treatment with a regimen including pyrazinamide].
Miyazawa N; Horita N; Tomaru K; Tsukahara T; Takahashi R; Sasaki M; Ishigatsubo Y
Kekkaku; 2013 Mar; 88(3):297-300. PubMed ID: 23672170
[TBL] [Abstract][Full Text] [Related]
3. [Hyperuricemia and arthralgia during pyrazinamide treatment].
Inoue T; Ikeda N; Kurasawa T; Sato A; Nakatani K; Ikeda T; Yoshimatsu H
Nihon Kokyuki Gakkai Zasshi; 1999 Feb; 37(2):115-8. PubMed ID: 10214039
[TBL] [Abstract][Full Text] [Related]
4. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Ijaz K; McElroy PD; Navin TR
Clin Infect Dis; 2004 Jul; 39(2):289. PubMed ID: 15307044
[No Abstract] [Full Text] [Related]
5. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
Wada M
Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
[TBL] [Abstract][Full Text] [Related]
6. [Observations on the effect of PZA, EB and RFP on uric acid metabolism].
Dong SQ
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Aug; 9(4):220-2, 254. PubMed ID: 3568913
[No Abstract] [Full Text] [Related]
7. Epidemiological survey of hyperuricemia as an adverse reaction to antituberculous therapy with pyrazinamide.
Taki H; Ogawa K; Murakami T; Nikai T
Kekkaku; 2008 Jul; 83(7):497-501. PubMed ID: 18709966
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of tuberculosis in the adult].
Schrappe M; Wassermann K; Kroegel C
Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
[No Abstract] [Full Text] [Related]
9. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
Koumbaniou C; Nicopoulos C; Vassiliou M; Manda-Stachouli C; Sakellariou K; Demou GS; Constantopoulos SH
Int J Tuberc Lung Dis; 1998 Aug; 2(8):675-8. PubMed ID: 9712283
[TBL] [Abstract][Full Text] [Related]
10. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
Gned'ko NI
Voen Med Zh; 2002 May; 323(5):56-8. PubMed ID: 12073843
[No Abstract] [Full Text] [Related]
11. [Cutaneous reaction after pyrazinamide initiation].
Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
[No Abstract] [Full Text] [Related]
12. [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
Fiala W; Häcki MA; Brändli O
Schweiz Med Wochenschr; 1983 Dec; 113(51):1956-9. PubMed ID: 6658432
[TBL] [Abstract][Full Text] [Related]
13. [On the problem of chronic liver damage following drug therapy of tuberculosis].
Petera V; Klapálek D; Paichl P; Pecený A
Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
[No Abstract] [Full Text] [Related]
14. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ; Perng RP
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
[TBL] [Abstract][Full Text] [Related]
15. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
16. Side effects of antituberculosis drugs.
Mohan A; Sharma SK
Am J Respir Crit Care Med; 2004 Apr; 169(7):882-3. PubMed ID: 15044223
[No Abstract] [Full Text] [Related]
17. [Survey of anti-tuberculosis drug-induced severe liver injury in Japan].
Shigeto E;
Kekkaku; 2007 May; 82(5):467-73. PubMed ID: 17564126
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide-induced anaphylaxis: diagnosed by skin test and successful desensitization.
Bavbek S; Yılmaz I; Aydın Ö; Ozdemir SK
Int Arch Allergy Immunol; 2012; 157(2):209-12. PubMed ID: 21986254
[TBL] [Abstract][Full Text] [Related]
19. [DRUG-INDUCED LIVER INJURY AND PYRAZINAMIDE USE].
Horita N; Miyazawa N
Kekkaku; 2015 Mar; 90(3):401-5. PubMed ID: 26477109
[TBL] [Abstract][Full Text] [Related]
20. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
Garca-Doval I
J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
